Skip to main content
. Author manuscript; available in PMC: 2009 Jun 10.
Published in final edited form as: Gynecol Oncol. 2007 Jul 5;106(3):469–475. doi: 10.1016/j.ygyno.2007.05.008

Table 4.

Patients with PFS2 > PFS1

Patient no. Dur PFS1 Dur PFS2 Difference
8 15.2 mos 15.5 mos 0.3 mos
16 8.8 mos 10.5 mos 1.7 mos
17 10.4 mos 17.1 mos 6.7 mos

PFS1, the interval from the start of primary therapy to date of first relapse; PFS2, the interval from the start of secondary therapy to the date of the second relapse.